Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. CT ORDER Other Confidential Order
  4. CERT Other Certification
  5. 8-A12B Other Registration of Securities
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1/A Offering Registration Statement
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1/A Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. S-1 Offering Registration Statement
  17. DRS/A Other Draft Registration Statement
  18. DRSLTR Other Correspondence Related to Draft Registration Statement
  19. DRS/A Other Draft Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 33 of 34 · 662 filings